Clinical Trials Logo
  1. Home
  2. Pain, Acute
  3. NCT05498025
  4. Details
NCT05498025 Clinical Trial

The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery

Pain, Acute Clinical Trial

Official title:
The Effect of a Charcoal Deactivation Pouch on Opioid Disposal After Cesarean Delivery

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05498025
Other study ID # 2022-0487
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 21, 2023
Est. completion date July 29, 2023

Study information
Verified date January 2024
Source Geisinger Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: There is scarce literature investigating how patients dispose of unused opioid supplies after their cesarean postoperative pain has faded. The Office of the Surgeon General has identified research on the prevention of opioid use disorder area as well as research on the management of pain as a "Surgeon General Priority" that needs urgent investigation. Hypothesis: At least 33% of postpartum women discharged home with an opioid prescription and a drug deactivation pouch will use the pouch to dispose of remaining opioids within 30 days of delivery. Methods: This is a prospective single arm interventional pilot study.

Recruitment information / eligibility
Status Completed
Enrollment 37
Est. completion date July 29, 2023
Est. primary completion date July 29, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 55 Years
Eligibility Inclusion criteria: - Age 18+ at time of enrollment, per ERM - Delivered =26.0 weeks, per ERM - Status post low transverse cesarean delivery, per ERM - Physically located on labor & delivery and is postpartum day #1 or #2 at time of enrollment, per ERM - Opioid prescription has been sent (per ERM) or will be sent (per obstetric team). Exclusion criteria: - Positive urine toxicology anytime in pregnancy for non-prescription opioids, fentanyl, amphetamines, benzodiazepines, cannabinoids, LSD, or cocaine, per ERM. - Buprenorphine or methadone Rx, per ERM - Patient preferred communication language not English, per ERM - Documented history, per ERM: - Cannabinoid use disorder - Hypnotic use disorder - Opioid use disorder - Stimulant use disorder - Fibromyalgia - Sickle cell anemia - Lumbar disc herniation - Multiple sclerosis - Trigeminal neuralgia - Active cancer - Complex regional pain syndrome - Systemic lupus erythematosus - Rheumatoid arthritis

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Deterra activated charcoal pouch
drug disposal pouch

Locations
Country Name City State
United States Geisinger Medical Center Danville Pennsylvania

Sponsors (1)
Lead Sponsor Collaborator
Geisinger Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Actual pouch use The percentage of women who used the pouch to dispose of opioids in the home 30 days after delivery (%) 30 days
See also
  Status Clinical Trial Phase
Completed NCT04356963 - Adjunct VR Pain Management in Acute Brain Injury N/A
Recruiting NCT06350084 - Effect of Mother's Touch and Nurse's Therapeutic Touch on Pain Level and Crying Time During Heel Blood Collection N/A
Completed NCT04080037 - Assessing Opioid Care Practices Using CPV Patient Simulation Modules N/A
Recruiting NCT05458037 - RCT of Pain Perception With Fast and Slow Tenaculum Application N/A
Completed NCT04571515 - Dose-Response Study of MR-107A-01 in The Treatment of Post-Surgical Dental Pain Phase 2
Recruiting NCT06005480 - Understanding Rebound Pain After Regional Anesthesia Resolution in Healthy Volunteers Phase 1
Active, not recruiting NCT04850079 - EHR Precision Drug Treatment in Neonates
Completed NCT03272139 - Interscalene Block Versus Superior Trunk Block Phase 4
Completed NCT03271151 - Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty Phase 4
Recruiting NCT05383820 - Effect of Paracetamol and Ketorolac on RANK-L Levels in Patients Starting Orthodontic Treatment Phase 4
Completed NCT04851353 - Multiple Sensory Interventions On Infants' Pain and Physiological Distress During Neonatal Screening Procedures N/A
Completed NCT03280017 - Ketamine With Multilevel Paravertebral Block for Post Video-assisted Thoracic Surgery Pain Phase 4
Completed NCT04280796 - Changes in Affective Pain Processing in Human Volunteers N/A
Not yet recruiting NCT04491630 - COping With PAin Through Hypnosis, Mindfulness and Spirituality N/A
Not yet recruiting NCT04523623 - Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries N/A
Not yet recruiting NCT04062513 - Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response N/A
Withdrawn NCT03137017 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults Phase 1
Withdrawn NCT03137030 - A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults Phase 1
Completed NCT04659395 - How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block N/A
Recruiting NCT03257319 - Inhaled vs IV Opioid Dosing for the Initial Treatment of Severe Acute Pain in the Emergency Department Phase 3